U.S. Market and Survey for Retinopathy Screening Devices
Abstract:
The market for diabetic retinopathy screening devices is in its infancy. Growth is expected under all forecast scenarios; however, the rate of growth will be determined by pricing and reimbursement. Several different strategies to promote widespread screening for diabetic retinopathy are being implemented across the United States and around the world. In the U.S., the success of these strategies will depend on the extent to which they are able to provide much needed services in a way that is sustainable under evolving economic and legislative conditions. Successful strategies for bringing solutions to market will be informed by the preferences of physicians and other health care providers in the context of legislative incentives, economic constraints and the demands of a changing patient population. This report, based on a combined market and end-user study, is designed to act as a guidebook for companies and policy makers attempting to navigate this complex economic and political landscape.
Scope of Report: This report pertains to a forecast period of 7 years (2013 – 2020) for the U.S. market.
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
The market for diabetic retinopathy screening devices is in its infancy. Growth is expected under all forecast scenarios; however, the rate of growth will be determined by pricing and reimbursement. Several different strategies to promote widespread screening for diabetic retinopathy are being implemented across the United States and around the world. In the U.S., the success of these strategies will depend on the extent to which they are able to provide much needed services in a way that is sustainable under evolving economic and legislative conditions. Successful strategies for bringing solutions to market will be informed by the preferences of physicians and other health care providers in the context of legislative incentives, economic constraints and the demands of a changing patient population. This report, based on a combined market and end-user study, is designed to act as a guidebook for companies and policy makers attempting to navigate this complex economic and political landscape.
Scope of Report: This report pertains to a forecast period of 7 years (2013 – 2020) for the U.S. market.
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment
- Trend Analysis by Segment
- Market Drivers & Limiters
- Customer Feedback & Market Monitoring
- U.S. Diabetic Retinopathy Screening Device Market
- Aggregate Diabetic Retinopathy Screening Device Market
- Alternative Location Diabetic Retinopathy Screening Device Market
- Physician and Hospital Administrator Survey
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
EXECUTIVE SUMMARY
1.1 SCOPE OF STUDY
1.2 MARKET ANALYSIS AND FORECASTS
1.3 PHYSICIAN AND HOSPITAL ADMINISTRATOR SURVEY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
2.2.1 Step 1: Project Initiation & Team Selection
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
2.2.4 Step 4: Performing Primary Research
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
2.2.6 Step 6: Market Forecast and Analysis
2.2.7 Step 7: Identify Strategic Opportunities
2.2.8 Step 8: Final Review and Market Release
2.2.9 Step 9: Customer Feedback and Market Monitoring
U.S. DIABETIC RETINOPATHY SCREENING DEVICE MARKET
3.1 INTRODUCTION
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 Aggregate Diabetic Retinopathy Screening Device Market
3.2.2 Alternative Location Diabetic Retinopathy Screening Device Market
3.2.2.1 Alternative Projection: Stable Prices and No Reimbursement
3.2.2.2 Alternative Projection: Price Erosion
3.2.2.3 Alternative Projection: Reimbursement
3.2.3 Comparison of Alternative Projections
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE ANALYSIS
3.4.1 Leading Competitors
PHYSICIAN AND ADMINISTRATOR SURVEY
4.1 INTRODUCTION
4.2 AWARENESS OF ISSUE
4.3 MOTIVATION TO OBTAIN
4.3.1 Introduction
4.3.2 Results
4.3.2.1 Perceived Impact of Diabetic Retinopathy Screening Equipment
4.3.2.2 Motivation to Obtain Diabetic Retinopathy Screening Equipment
4.4 PRICE SENSITIVITY
4.5 RELATIONSHIPS WITH EYE SPECIALISTS
ABBREVIATIONS AND SURVEY APPENDIX DATA
5.1 ABBREVIATIONS
5.2 PRICING SENSITIVITY BY GROUP
5.2.1 Hospital Administrators
5.2.2 Group Practice PCPs
5.2.3 Endocrinologists
1.1 SCOPE OF STUDY
1.2 MARKET ANALYSIS AND FORECASTS
1.3 PHYSICIAN AND HOSPITAL ADMINISTRATOR SURVEY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
2.2.1 Step 1: Project Initiation & Team Selection
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
2.2.4 Step 4: Performing Primary Research
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
2.2.6 Step 6: Market Forecast and Analysis
2.2.7 Step 7: Identify Strategic Opportunities
2.2.8 Step 8: Final Review and Market Release
2.2.9 Step 9: Customer Feedback and Market Monitoring
U.S. DIABETIC RETINOPATHY SCREENING DEVICE MARKET
3.1 INTRODUCTION
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 Aggregate Diabetic Retinopathy Screening Device Market
3.2.2 Alternative Location Diabetic Retinopathy Screening Device Market
3.2.2.1 Alternative Projection: Stable Prices and No Reimbursement
3.2.2.2 Alternative Projection: Price Erosion
3.2.2.3 Alternative Projection: Reimbursement
3.2.3 Comparison of Alternative Projections
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE ANALYSIS
3.4.1 Leading Competitors
PHYSICIAN AND ADMINISTRATOR SURVEY
4.1 INTRODUCTION
4.2 AWARENESS OF ISSUE
4.3 MOTIVATION TO OBTAIN
4.3.1 Introduction
4.3.2 Results
4.3.2.1 Perceived Impact of Diabetic Retinopathy Screening Equipment
4.3.2.2 Motivation to Obtain Diabetic Retinopathy Screening Equipment
4.4 PRICE SENSITIVITY
4.5 RELATIONSHIPS WITH EYE SPECIALISTS
ABBREVIATIONS AND SURVEY APPENDIX DATA
5.1 ABBREVIATIONS
5.2 PRICING SENSITIVITY BY GROUP
5.2.1 Hospital Administrators
5.2.2 Group Practice PCPs
5.2.3 Endocrinologists
